Change in immune response in children suffering from opisthorchosis and attempt at its correction using Levamisol

Journal of Hygiene, Epidemiology, Microbiology, and Immunology
|January 1, 1984
PubMed

The number of circulating T-, B- and O-lymphocytes, the activity of non-specific T-suppressors, the ability of lymphocytes to blasttransformation with PHA and the levels of M, G and A immunoglobulins in blood serum were studied in 40 children suffering from chronic opisthorchosis and in 18 virtually healthy children (mean age 9 years). The affected children were studied before and after treatment with Levamisol. It has been established that the number of T-lymphocytes is reduced and the activity of non-specific T-suppressors decreases considerably in children suffering from chronic opisthorchosis which by its nature is a heavy allergosis. Through a similar factor, the inhibition of the activity of T-helpers is reduced and conditions are created for increased antibody production in the organism of the patients without an increase in the level of B-lymphocytes. Consequently, manifestations of autoimmune and allergic reactions of the immediate and delayed type can be expected to occur in such patients. Treatment of the affected children with Levamisol (2 mg/l kg body mass every other day, 3 administrations of the preparation in one course) showed an immunoregulative effect characterized by intensification of the formerly reduced activity of T-suppressors (P less than 0.001), decrease in the number of B-lymphocytes in the peripheral blood and normalization of IgA concentration in blood serum. It is recommended to include Levamisol, together with anthelminthics, in complex opisthorchosis therapy so as to realize its immunoregulative effect because the antiparasitic therapy using Chloxil (anthelmithic), while showing good dehelminthizing results, failed to promote correction of immune disturbances observed during opisthorchis invasion and in opisthorchosis convalescents.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...